European Pharmaceutical Review

JANUARY 29, 2024

Repurposing of currently marketed products, eg, methotrexate, 20 was an important and effective strategy in combatting COVID-19, particularly in the early stages prior to effective vaccines being developed. EMA initiatives for acceleration of development support and evaluation procedures for COVID-19 treatments and vaccines [OBSOLETE].

FDA 111

FDA Vaccines Compounding 111

Hospital Pharmacy Europe

NOVEMBER 23, 2023

The statements, which were adopted in 2014, express commonly agreed objectives which every European health system should aim for in the delivery of hospital pharmacy services. Few barriers were identified for hospital pharmacies to engage in the procurement, compounding and the distribution of medicines.

Hospitals 52

Hospitals Compounding Patient Care Vaccines 52

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

Vaccines 97

Vaccines Compounding Documentation FDA 97

ISPE

SEPTEMBER 11, 2023

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” New Project: Evolutive Vaccines Facility for Sanofi.”

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

pharmaphorum

DECEMBER 2, 2020

It was at this time they set their site at Sandwich in the UK, initially just to finish processing compounds imported from America, but due to tariffs on imported products the company rapidly expanded the plant to accommodate producing medicines from scratch. Likewise, tanezumab, an anti-osteoarthritic, failed in trials.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

ISPE

MARCH 8, 2023

5 , 8 Compounding pharmacies were commonly mentioned as sources of microbial cross-contamination, especially in the US. 9 , 15 This has led to compounding pharmacies completing high-volume activities such as mass repackaging, thereby increasing the risk of cross-contamination. million vials, 26 had to be recalled and destroyed.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52